Day One - CT (Central Time)
Start your journey through the complex world of government contracting with this essential primer.
- Miree Lee, MS, MBA - Bio/Pharma Pricing, Contracts & Compliance Consultant, M.Lee Consulting LLC
Comprehensive examination of core Medicaid pricing methodologies, calculation requirements, and reporting obligations that form the foundation of government pricing compliance.
- Miree Lee, MS, MBA - Bio/Pharma Pricing, Contracts & Compliance Consultant, M.Lee Consulting LLC
Examine the mechanics of state rebate programs, including documentation standards and approaches to processing both standard and supplemental rebates across different state systems.
- Josephine Hawkins - Associate Director, Medicaid, AstraZeneca
- Dive deep into Advanced AMP calculation scenarios using real-world, blinded case studies
- Explore the impact of 70/30 calculations on AMP and learn strategic modeling techniques
- Interactive workshop featuring insights from industry experts and legal perspectives
- Practical guidance for navigating complex manufacturer pricing calculations
- Amanda Tucker - Associate Director, Solution Delivery, Northridge Insight
- Quantify 340B impact, optimize rebate compliance, mitigate reimbursement risks
- Evaluate specialty pharmacy partnerships, analyze exclusive distribution models, optimize channel economics
- Design adaptive pricing models, integrate medical claims data, enhance gross-to-net forecasting
- Tom Evegan - Principal, Strategy & Management Consulting, RSM US LLP
- Navigate new reporting obligations in key states with detailed timeline and requirement analysis
- Implement automated validation systems to manage increasing data complexity across state programs
- Create sustainable processes to track evolving state requirements and upcoming legislation
- Lynetta Moore - Director, State Price Transparency Reporting, IntegriChain
- Learn how your peers are addressing SPTR management, operations, and compliance
- Gain more understanding of best practices that you can apply in your organization
- Hear perspectives on future developments
- John McGrory - CEO, ClassOne Insight
- Claims processing and resolving disputes in light of new IRA requirements
- State-specific formulary management and PDL decision-making processes
- Effective P&T committee presentation strategies for manufacturers
- Administrative efficiency improvements for rebate processing
- 340B claims identification and reconciliation approaches
- Navigating increased state data submission requirements and enforcement
- Coordinating implementation of new federal and state policy changes
- Nichole Palusinski Pharm.D - Clinical Pharmacist, IL HFS Medicaid Drug Rebate Unit
- Cathy Burton-Meza - Associate Director, Government Rebates, Gilead Sciences
- Sherry Kindred - Senior Director Drug Rebate, Gainwell
- Antoine Nelson - Director, Pharmaceutical Rebate Operations, Government Healthcare Solutions, Conduent
- Amanda Caire - ., Gainwell
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.
AK, AZ, AR, CA (ADAP), CO, CT (ADAP), CT (DSP), DC, GA, ID (ADAP), ID, LA, MD, MI, MT, MN, NE, NH, NY, NV, NV (ADAP), NC, PA, RI, SC, VA, WI (DSP)
- Jeanine Lundeberg - Director, Pharmacy Rebate Management, Prime Therapeutics
- Dena Karels - CPhT Lead, Manager, Rebate Dispute Management, Prime Therapeutics
Essential structure for understanding 340B program eligibility, covered entity requirements, manufacturer obligations, and the fundamental principles governing this complex discount program.
- Michelle Drozd - Executive Director and Head, US Pricing Policy & Analytics, Gilead
This session explores the complex and evolving requirements of recalculations and effective executive management communication. Topics include potential recalculation drivers, current regulatory requirements across Medicaid, Medicare, VA and 340B programs, agency communications, materiality considerations, executive management information needs, mitigation planning strategies, and step-by-step recalculation approaches.
- Chris Cobourn - Managing Director, Helio GP Advisory Services
- Marijo Bustos - Head of Government Pricing and Reimbursement, UCB Inc
- Understanding complex trade assignment rules and strategic implications
- Real-world calc drivers and impact of contracting decisions, predictive modeling
- Optimizing pricing compliance while maintaining competitive market positioning
•Harmonizing methodologies and GP assumptions for product acquisitions, divestitures and launches
• Government program participation strategies
• Practical insights and best practices from recent experiences
Join us for this deep dive workshop into the ever-changing active and pending SPTR laws from the legal and operational perspectives.
- Gregg Kasten - Vice President, Products and Services, ClassOne Insight
- Trevor Wear - Partner, Sidley Austin LLP
- Claims processing and resolving disputes in light of new IRA requirements
- State-specific formulary management and PDL decision-making processes
- Effective P&T committee presentation strategies for manufacturers
- Administrative efficiency improvements for rebate processing
- 340B claims identification and reconciliation approaches
- Navigating increased state data submission requirements and enforcement
- Coordinating implementation of new federal and state policy changes
- Nichole Palusinski Pharm.D - Clinical Pharmacist, IL HFS Medicaid Drug Rebate Unit
- Cathy Burton-Meza - Associate Director, Government Rebates, Gilead Sciences
- Sherry Kindred - Senior Director Drug Rebate, Gainwell
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.
Overview of Medicare Part B program structure, ASP calculation basics, and reporting requirements critical for products administered in physician offices and outpatient settings.
Introduction to Medicare's prescription drug benefit program structure, manufacturer obligations, and key calculations affecting covered medications for beneficiaries.
- Judd Caulfield - Senior Counsel, Takeda Pharmaceuticals
- Operational considerations for new pharmaceutical companies
- Explore effective organizational structures for managing 340B programs as companies grow, including cross-functional centers of excellence that bridge legal, compliance, market access, and finance responsibilities
- Darnell Turner - Executive Director - Government Pricing & Market Access Operations, Exelixis Inc
- Sharon Small - Director, Counsel Market Access, Government Pricing & Policy, Novartis Pharmaceuticals Corporation
- Developing Your Initial Government Pricing and Reimbursement Model
- Developing internal calculation frameworks
- Tools for accurate government pricing assessment
- Oonagh O'Malley - Associate Director, Government Pricing & Reporting, Insmed Incorporated
- Kavita Gupta - Director, GP, Sandoz
- Discuss elements of the pharmaceutical pricing agreement
- Describe 340B ceiling price calculation
- Identify pricing responsibilities with HRSA and wholesalers
- Mike Benedict, MS, RPh - Vice President, Operations, Apexus
- Share leading practices in good-faith inquiries
- Understand the guidelines for manufacturer audits and the dispute resolution process
- Review results of recent HRSA audits of manufacturers and covered entities
- Describe the process for developing and implementing a successful corrective action plan (CAP)
- John Barnes, CPM, MBA, 340B AC - Vice President, Pharmaceutical Contracting, Apexus
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.
Please sign up onsite at registration desk on September 15.
• Delaware • District of Columbia • Hawaii • Illinois • Kentucky • Maryland • Massachusetts • New Mexico
- Nichole Palusinski Pharm.D - Clinical Pharmacist, IL HFS Medicaid Drug Rebate Unit
- Dorine Rascoe - Division Chief, Drug Rebates and Lockbox Services, Office of Finance, Medical Care Programs, Maryland Department of Health
- Tykeisha Corbett - Administrator II, Drug Rebate and Lockbox Services Unit, Office of Finance, Maryland Department of Health
- Sherry Kindred - Senior Director Drug Rebate, Gainwell
- Antoine Nelson - Director, Pharmaceutical Rebate Operations, Government Healthcare Solutions, Conduent
- Felicia DiPaolo - Director, Medicaid Drug Rebates, MedImpact
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.
Foundational knowledge of Veterans Affairs contracting requirements, pricing obligations, and essential compliance considerations for pharmaceutical manufacturers.
- Ted Karnezis, RPh - President/Owner, Karnezis Consulting
Basic framework for understanding the Inflation Reduction Act's pharmaceutical provisions and initial steps toward implementing compliant processes and systems.
- Kristina Roach - Customer Success Officer, RevSavvy
- Strategies for launching new drugs
- Develop multi-channel market access strategies
- Elizabeth Lindquist - Partner, Arnold & Porter
- Identify price adjustment triggers across therapeutic categories
- Build scenario planning models for IP and market disruptions
- Develop dynamic pricing strategies responsive to market conditions
- Marcella Lynch - Director- Forecasting & Pricing Market Access- Rare Diseases, Chiesi USA, Inc.
- Dave Evans - Senior Director Pricing & Contracting Global Value Access & Distribution, Cytokinetics
- Discuss covered entity inventory management models and purchasing account setups
- Identify contracting methodologies and the procurement activities related to 340B program requirements
- Michael Peters, PharmD, MBA, BCPS - 340B ACE, 340B Policy and Compliance Director, Apexus
- Explain the types of contracts loaded to covered entity purchasing accounts and drivers of purchasing from different accounts
- Identify contracting methodologies and the procurement activities related to 340B program requirements
- Broderick Olson - Director, Contract Services, Pharmacy, Apexus
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.
Please sign up onsite at registration desk on September 15.
• Delaware • District of Columbia • Hawaii • Illinois • Kentucky • Maryland • Massachusetts • New Mexico
- Nichole Palusinski Pharm.D - Clinical Pharmacist, IL HFS Medicaid Drug Rebate Unit
- Sherry Kindred - Senior Director Drug Rebate, Gainwell
- Dorine Rascoe - Division Chief, Drug Rebates and Lockbox Services, Office of Finance, Medical Care Programs, Maryland Department of Health
- Tykeisha Corbett - Administrator II, Drug Rebate and Lockbox Services Unit, Office of Finance, Maryland Department of Health
- Antoine Nelson - Director, Pharmaceutical Rebate Operations, Government Healthcare Solutions, Conduent
- Felicia DiPaolo - Director, Medicaid Drug Rebates, MedImpact
- Kathy Thomas - ., Gainwell
Targeted discussions between manufacturers and States to resolve rebates, reporting, and compliance questions.